Real-World Use of Voclosporin in UK Lupus Nephritis Patients: Results from the British Isles Lupus Assessment Group Biologics Registry (BILAG-BR) (EULAR 2026) - Mar 18, 2026 - Abstract #POS0691; B.1345; K204; Pres time: Jun 4, 2026; 09:30 AM - 10:30 AM; Location: Poster View; "We also noted concomitant biologic use in 32% (belimumab or rituximab) of those in the voclosporin cohort. These findings highlight proactive treatment strategies and equitable access to advanced therapies. Long-term follow-up will assess effectiveness, steroid-sparing potential, and safety."
Clinical • Real-world • Real-world evidence • Chronic Kidney Disease • Glomerulonephritis • Immunology • Inflammatory Arthritis • Lupus • Lupus Nephritis • Nephrology
|
|
Emily Sutton 1; Mia Rodziewicz1; Sarah Dyball1; Alison Fountain1; Ben Parker1, 2; Ian Bruce3
|